Sutro Biopharma, Inc 10-Q for FY2021 Q3
Sutro Biopharma, Inc. (STRO)
10-Q
2021-11-10
For: 2021-09-30
View Original
Added on
April 11, 2026
About this 10-Q
Sutro Biopharma, Inc filed this 10-Q on November 10, 2021, covering the quarter ended September 30, 2021 (FY2021 Q3).
Headline figures
Quarter ended September 30, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $8.52M
- down 52.2% from $17.82M a year earlier
- Net loss
- $30.9M
- compared with net income of $17.14M a year earlier
- Diluted EPS
- -$0.67
- compared with $0.45 a year earlier